These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38715343)

  • 1. Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis.
    Zhou Y; Ding Y; Cui M; Zhang Y; Wang M; Zhou F; Su Y; Liang B; Zhou F
    Med Sci Monit; 2024 May; 30():e943360. PubMed ID: 38715343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of ANxA6 Gene Polymorphism on the Efficacy of Methotrexate Treatment in Psoriasis Patients.
    Fan Z; Zhang Z; Huang Q; Han L; Fang X; Yang K; Wu S; Zheng Z; Yawalkar N; Wang Z; Yan K
    Dermatology; 2021; 237(4):579-587. PubMed ID: 33582672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
    Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of disease severity with IL-1 levels in methotrexate-treated psoriasis patients.
    Tamilselvi E; Haripriya D; Hemamalini M; Pushpa G; Swapna S
    Scand J Immunol; 2013 Dec; 78(6):545-53. PubMed ID: 24283773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial.
    Liu LF; Chen JS; Gu J; Xu JH; Jin HZ; Pang XW; Wang G; Yu C; Song ZQ; Guo ZP; Li W; Lai W; Cui PG; Chen M; Fang H; Lyu CZ; Li YZ; Sun Q; Xie HF; Liu XM; Gao XH; Shi YL; Zhao NQ; Zhang W; Zheng M
    Arch Dermatol Res; 2020 Aug; 312(6):437-445. PubMed ID: 31873772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio.
    Wang B; Deng H; Hu Y; Han L; Huang Q; Fang X; Yang K; Wu S; Zheng Z; Yawalkar N; Zhang Z; Yan K
    Arthritis Res Ther; 2022 Jan; 24(1):17. PubMed ID: 34996506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of methotrexate (0.3 mg/kg/week) versus a combination of methotrexate (0.15 mg/kg/week) with cyclosporine (2.5 mg/kg/day) in chronic plaque psoriasis: A randomised non-blinded controlled trial.
    Singh SK; Singnarpi SR
    Indian J Dermatol Venereol Leprol; 2021; 87(2):214-222. PubMed ID: 33769732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis.
    Qiu Q; Deng J; Deng H; Yao D; Yan Y; Ye S; Shang X; Deng Y; Han L; Zheng G; Roy B; Chen Y; Han L; Huang R; Fang X; Lu C
    Front Immunol; 2022; 13():937539. PubMed ID: 36159864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TT genotype of rs10036748 in TNIP1 shows better response to methotrexate in a Chinese population: a prospective cohort study.
    Yan KX; Zhang YJ; Han L; Huang Q; Zhang ZH; Fang X; Zheng ZZ; Yawalkar N; Chang YL; Zhang Q; Jin L; Qian DF; Li XY; Wu MS; Xu QH; Zhang XJ; Xu JH
    Br J Dermatol; 2019 Oct; 181(4):778-785. PubMed ID: 31020648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
    Tournier A; Khemis A; Maccari F; Reguiai Z; Bégon E; Fougerousse AC; Amy de la Breteque M; Beneton N; Parier J; Boyé T; Avenel-Audran M; Girard C; Pallure V; Perrot JL; Bastien M; Mahé E; Beauchet A;
    Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients.
    Elango T; Dayalan H; Subramanian S; Gnanaraj P; Malligarjunan H
    Clin Chim Acta; 2012 Oct; 413(19-20):1652-6. PubMed ID: 22609260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?
    Zhai Z; Chen L; Yang H; Yan J; Wang C; Yang J; Liu W; Shen Z
    J Am Acad Dermatol; 2015 Dec; 73(6):991-7.e3. PubMed ID: 26416303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of psoriasis severity and inflammatory responses under concomitant treatment with methotrexate plus micronutrients for psoriasis vulgaris: a randomized double blind trial.
    Yousefzadeh H; Jabbari Azad F; Banihashemi M; Rastin M; Mahmoudi M
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):3-9. PubMed ID: 28352928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Alabas OA; Mason KJ; Yiu ZZN; Warren RB; Lunt M; Smith CH; Griffiths CEM;
    Br J Dermatol; 2023 Aug; 189(3):271-278. PubMed ID: 37226927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.